Calcium metabolism, arterial stiffness and 24-hour blood pressure monitoring data in postmenopausal women with magnesium deficiency, hypertension, and heart failure

Aim. To assess the calcium metabolism, arterial stiffness and 24-hour blood pressure (BP) monitoring data in postmenopausal women with magnesium deficiency, hypertension, and heart failure with preserved ejection fraction (HFpEF)

Material and methods. The study involved 140 female patients with hypertension complicated by HFpEF, aged 52 to 76 years. Depending on the results of magnesium-tolerance test, 2 groups were selected. The first group consisted of 72 females with magnesium deficiency, and the second (control) group (n=68) — without magnesium deficiency. Calcium metabolism was assessed using calcium-tolerance test. Twenty-four-hour blood pressure monitoring and arterial stiffness was determined using an automatic blood pressure monitor.

Results. Patients with magnesium deficiency had a lower calcium excretion and return to baseline blood calcium levels compared with group 2 (p<0,001). The presence of magnesium deficiency was associated with an increase in 24-hour BP variability (16,9 [13,3; 20,69] mm Hg vs 12,9 [11,7; 17,42] mm Hg; p=0,001), rate of morning BP rise (12,5 [9,7; 13,6] mm Hg/h vs 9,5 [8,1; 10,9] mm Hg/h; p<0,001) and indexed systolic BP (21,2 [19,5; 25,1] mm Hg vs 19,5 [16,5; 23,9] mm Hg; p=0,007). In women with magnesium deficiency, BP pro -files of non-dipper and night-peaker were more common (p<0,05). Pulse wave velocity (11,92 [10,06; 14,47] m/s vs 10,87 [8,41; 13,20] m/s; p=0,005) and central pulse pressure (70,2±13,3 mm Hg vs 63,5±12,5 mm Hg; p=0,003) were also higher in group 1. Also, a correlation ( р=-0,610, p<0,001) was found between the rate of exercise-induced decrease in blood calcium and the pulse wave velocity.

Conclusion. In women with hypertension and HFpEF, there were no differences in mean 24-hour BP values, while more unfavorable BP profiles and arterial stiffness indicators were revealed, which is mediated by impaired oalcium metabolism.

1. Fomin IV. Chronic heart failure in Russian Federation: what do we know and what to do. Russian Journal of Cardiology. 2016;(8):7-13. (In Russ.). doi:10.15829/1560-4071-2016-8-7-13.

2. Shah SJ, Kitzman DW, Borlaug BA, et al. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap. Circulation. 2016;134(1):73-90. doi:10.1161/CIRCULATIONAHA.116.021884.

3. Tangvoraphonkchai K, Davenport A. Magnesium and Cardiovascular Disease. Adv Chronic Kidney Dis. 2018;25(3):251-60. doi:10.1053/j.ackd.2018.02.010.

4. Mailian DE, Kolomiets VV. The role of calcium metabolism dysregulation in the pathogenesis of cardiovascular diseases. Russian Journal of Cardiology. 2019;(9):78-85. (In Russ.) doi:10.15829/1560-4071-2019-9-78-85.

5. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. doi:10.1093/eurheartj/ehy339.

6. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37(27):2129-200. doi:10.1093/eurheartj/ehw128.

7. Kondakov AV, Kobylyansky AG, Tischenkov VG. The functional tests in clinical diagnostic laboratory: the detection of magnesium. Klinicheskaya Laboratornaya Diagnostika. 2012;(6):16-20. (In Russ.)

8. Kolomiets VV, Bobrova OV. Essential hypertension and calcium homeostasis. Kyiv: Chetvertaya volna, 1998. p. 196. (In Russ.) ISBN: 966529-046-0.

9. Castiglioni S, Cazzaniga A, Albisetti W, et al. Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients. 2013;5(8):3022-33. doi:10.3390/nu5083022.

10. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr. 2012;66(4):411-8. doi:10.3945/ajcn.117.155291.

11. Afsar B, Elsurer R. The relationship between magnesium and ambulatory blood pressure, augmentation index, pulse wave velocity, total peripheral resistance, and cardiac output in essential hypertensive patients. J Am Soc Hypertens. 2014;8(1):28-35. doi:10.1016/j.jash.2013.10.006.

12. Dumor K, Shoemaker-Moyle M. Arterial Stiffness in Hypertension. Curr Hypertens Rep. 2018;20(8):72. doi:10.1007/s11906-018-0867-x.

13. Hamaguchi K, Kurihara T, Fujimoto M, et al. Associations among Bone Mineral Density, Physical Activity and Nutritional Intake in Middle-Aged Women with High Levels of Arterial Stiffness: A Pilot Study. Int J Environ Res Public Health. 2020;17(5):1620. doi:10.3390/ijerph17051620.